Discover

ACCD
Accolade, Inc.
7.02
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
Ytd105.26%
1y-23.61%
7.02
day range
7.02
52 week range
Open7.02Prev Close7.02Low7.02High7.02Mkt CapN/A
Vol4.54MAvg Vol0.00EPSN/AP/EN/AForward P/E-4.05
Beta2.02Short Ratio2.59Inst. Own83.49%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d AvgN/A200-d AvgN/A1yr Est7.17
Earning
DateForEstimateReportedSurprisesurprise %
2025-01-092024-11-0.31N/AN/AN/A
2024-10-082024-08-0.45-0.30.1533.33%
2024-06-272024-05-0.48-0.350.1327.08%
2024-06-272024-05-0.48N/AN/AN/A
2024-04-252024-02-0.11-0.10.019.09%
2024-04-252024-02-0.11N/AN/AN/A
Upgrade / Downgrade
DateFirmActionFromTo
2024-12-17Morgan StanleyUpgradeEqual-WeightEqual-Weight
2024-10-11Wells FargoUpgradeEqual-WeightEqual-Weight
2024-10-09Truist SecuritiesUpgradeBuyBuy
2024-10-09Canaccord GenuityUpgradeBuyBuy
2024-10-09BarclaysUpgradeEqual-WeightEqual-Weight
2024-10-09Stephens & Co.UpgradeOverweightOverweight
Profile
Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.
Insider Holder
DateNameRelationQuantityDescription
2024-12-16BARNES STEPHEN H.Chief Financial Officer220.46KSale
2024-12-01BRODSKY JEFFREY SDirector44.63KConversion of Exercise of derivative security
2024-12-16CAVANAUGH ROBERT NPresident213.30KSale
2024-12-02ESKEW RICHARDGeneral Counsel62.51KSale
2024-12-15HILTON MICHAEL W.Director345.99KConversion of Exercise of derivative security
2024-08-05KLEIN PETER SDirector28.33KConversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Blackrock Inc.6.24M21.22M7.75%
2024-09-29Ah Capital Management, L.L.C. 5.40M18.36M6.70%
2024-09-29ARK Investment Management, LLC5.38M18.30M6.68%
2024-09-29Brown Advisory Inc.4.82M16.40M5.99%
2024-09-29Vanguard Group Inc4.16M14.13M5.16%
2024-09-29Millennium Management Llc3.99M13.56M4.95%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2024-10-30ARK ETF Tr-ARK Genomic Revolution ETF5.22M17.76M6.49%
2024-09-29Vanguard Total Stock Market Index Fund2.21M7.52M2.75%
2024-10-30iShares Russell 2000 ETF1.84M6.25M2.28%
2024-09-29Vanguard Extended Market Index Fund1.14M3.87M1.41%
2024-08-30Fidelity Small Cap Index Fund759.29K2.58M0.94%
2024-10-30iShares Russell 2000 Value ETF463.03K1.57M0.57%